CD19 and B-cell chronic lymphocytic leukemia: The percentage of TLR2-positive CD19+/CD5+ cells was significant higher in CLL patients with isolated del(13q14) (median: 0.72%) as compared to the patients with del(11q22) and/or del(17p13) (median: 0.24%) (p < 0.01).